Asymmetrex Approved to Conduct an ASTM Interlaboratory Evaluation of Its AlphaSTEM Test™ Technology as a Standard for Counting Therapeutic Adult Tissue Stem Cells

On May 16, at the ASTM International May Committee Meeting in Denver, Colorado, Massachusetts stem cell biotechnology company Asymmetrex received unanimous approval of its proposal for an interlaboratory evaluation of the company’s AlphaSTEM Test™ technology for counting therapeutic adult tissue stem cells. Highlighting the importance of the approval, a day earlier, the Standards Coordinating Body

May 21, 2019

Asymmetrex Presents Proposal for ASTM Interlaboratory Evaluation of AlphaSTEM Test™ Technology Towards Establishing A Standard for Counting Therapeutic Stem Cells

Today, May 16, at the ASTM International May Committee Meeting in Denver, Colorado, Massachusetts stem cell biotechnology company Asymmetrex will present a proposal for an interlaboratory evaluation of the company’s AlphaSTEM Test™. Approval of this ASTM evaluation will be an important step in Asymmetrex’s plan to establish the AlphaSTEM Test™ as a stem cell industry

May 16, 2019

Asymmetrex Publishes Chapter Explaining the Critical Need for Stem Cell Dosing

Since September 2018, Massachusetts stem cell biotechnology company Asymmetrex has been pursuing a campaign to increase awareness of the adult tissue stem cell counting problem in stem cell medicine and the stem cell supply industry. The latest 2018 installment in this effort is a book chapter, authored by Asymmetrex’s founder and director, that illuminates why

January 10, 2019

Asymmetrex Intensifies Campaign to Increase Awareness of the Adult Tissue Stem Cell Counting Problem

Since September of this year, stem cell biotechnology company Asymmetrex has been leading a campaign to increase awareness of the adult tissue stem cell counting problem in stem cell medicine and the stem cell supply industry. During the month of November, the company is intensifying this effort with new educational publications and presentations at clinical

November 7, 2018

Asymmetrex Increases Awareness on The Stem Cell Counting Problem

True or False for Stem Cell Awareness Day 2018 is an excellent and needed RegMedNet feature.  There are many misconceptions about stem cells in the research space, and even more misinformation or lacking information in the stem cell industrial space.  These sometimes surprising deficits in knowledge and understanding inhibit progress in stem cell medicine  and stem cell commercial

October 11, 2018

Understand Stem Cell Tools and How They Are Used

What is cryopreservation? Preserving by freezing, usually at extremely low temperatures (e.g., ≤ 130^oC). What is cryopreservation of cells? Freezing cells in a manner in which they remain viable after thawing. What is a blood spinning machine used for? To separate the cellular components of unclotted blood (red blood cells and white blood cells) from

October 10, 2018

Biomarker Development

Asymmetrex’s Adult Tissue Stem Cell Biomarker Technology Enables Cancer Stem Cell Research Cancer stem cells are cells found in tumors that have the ability to propagate the tumor after its dissociation.  In some tumors, this property is expressed by a large fraction of the total tumor cells, meaning abundant cancer stem cells.  However, in many

September 14, 2018

Adult Stem Cell Engineering

Asymmetrex’s SACK Technology Makes Adult Tissue Stem Cell Genetic Engineering a Simple Reality By providing highly enriched populations of tissue-specific adult stem cells, Asymmetrex’s SACK technology makes direct adult tissue stem cell engineering practical for the first time.  With SACK agent supplementation, cultures of SACK strains have stem cell fractions that range from 20% to

September 14, 2018

Identification of Adult Stem Cells

In Achieving the Technology for the Identification of Adult Stem Cells, and the Ability to Count Adult Tissue Stem Cells, Asymmetrex Will Change the Nature of Tissue Stem Cell Research and Biomedicine On April 29, 2015, Asymmetrex launched a one-year crowdsourcing campaign to engage the global tissue stem cell research community in the evaluation of Asymmetrex’s newest

September 14, 2018

Mouse | Rat | Human Tissue Cells

Regenerative Medicine is Awaiting the Mass Production of Therapeutic Adult Tissue Stem Cells that is Possible with Asymmetrex’s SACK Technology and Use of Mouse | Rat | Human Tissue Cells I. SACK Manufacturing of Human Adult Tissue Stem Cells Asymmetrex has a vision of developing SACK manufacturing-scale processes for mass production of human tissue stem

September 14, 2018

Next Page »